Oriola Corporation Investor News 8 October 2020 at 3.00 p.m. Oriola Corporation will publish its Interim report 1 January-30 September 2020 on Friday, 23 October 2020 approximately at 8.30 a.m.

Investor Relations. Financial Reports. Q4 2020. Q3 2020. Q2 2020. Q1 2020. Q4 2019. Q3 2019. Oriola provides an effective and reliable link between pharmaceutical

Regarding inquiries and meeting requests, you can send an email to investors(at With a market capitalization of €384m, Oriola Oyj is a small cap stock, so it might not be well known by many institutional investors. Our analysis of the ownership of the company, below, shows that institutional investors have bought into the company. We can zoom in on the different ownership groups, to learn more about Oriola Oyj. Oriola Corporation - Managers' transactions - Andersson _____ Person subject to the notification requirement Name: Andersson, Robert Position: Chief Executive Officer Issuer: Oriola Corporation LEI: 549300UWB1AIR85BM957 Notification type: INITIAL NOTIFICATION Reference number: 549300UWB1AIR85BM957_20200803110833_175 _____ Transaction date: 2020-07-31 Venue: XHEL Instrument type: SHARE ISIN Oriola Corporation Stock Exchange Release 23 February 2021 at 2.30 p.m. Oriola Corporation's Financial Statements 2020 and the Report of the Board of Directors is published. Oriola Corporation has today published its Report of the Board of Directors and Financial Statements for 2020. Milena Hæggström Head of Investor Relations and External Communications Tel. +358 40 5581 328 E-mail: milena.haeggstrom(at)caverion.com 7 May 2020. January - March 2020 Interim Report.

Oriola oyj investor relations

Oriola Oyj has 64 employees at this location and generates $1.90 billion in sales (USD). Orion publishes Financial Statement Release for 2020 on Tuesday 9 February 2021. 1/18/2021. Orion Animal Health and Vetoquinol expand collaboration – Vetoquinol to distribute Orion’s Clevor® in the USA and Orion to distribute Drontal® and Profender® products in Finland, Hungary and Romania. Investor information.

Capital Investors IV. Gunnebo Oriola Oyj och Fortaco Oy samt styrelseledamot i. Conficap Isabelle Ljunggren, Director Investor Relations.

We improve people's wellbeing by ensuring the reliable and customer-friendly delivery of pharmaceuticals and health products. Oriola provides an effective and reliable link between pharmaceutical companies and consumers. | Oriola Privacy Notice

Tervetuloa . Oriola Oyj Helena Kukkonen talous- ja rahoitusjohtaja . Lisätietoja: Katja Graff rahoitus- ja sijoittajasuhdepäällikkö puh.

Ahlstrom-Munksjö Oyj. Valuta INVESTOR A. Valuta INVESTOR B. Valuta LINK PROP INVESTMENT. Valuta Tre Kronor Property Investment AB. Valuta.

Tervetuloa. Oriola Oyj. Sari Aitokallio Talous- ja rahoitusjohtaja. Lisätietoja: Katja Graff rahoitus- ja sijoittajasuhdepäällikkö puh.

Orion publishes Financial Statement Release for 2020 on Tuesday 9 February 2021. 1/18/2021. Orion Animal Health and Vetoquinol expand collaboration – Vetoquinol to distribute Orion’s Clevor® in the USA and Orion to distribute Drontal® and Profender® products in Finland, Hungary and Romania. Investor information.
Huddinge skola läsår

Jakelu: Nasdaq Helsinki Oy Oriola Corporation Investor News 25 June 2020 at 12.00 p.m. Oriola Corporation will publish its Half year financial report 1 January-30 June 2020 on Friday, 17 July 2020 approximately at 8.30 a.m.

0104.
Impeller mercruiser

volvo 240 televerket
mintzberg configuration school
bergqvist massage & friskvårdsutbildningar malmö
personnummer sweden
kornmaltextrakt köpa

Oriola-KD Oyj pörssitiedote 6.3.2015 klo 13.00 Oriola-KD Oyj:n hallitus on tänään päättänyt kutsua koolle Oriola-KD Oyj:n varsinaisen yhtiökokouksen 30.3.2015.

by choosing our products. Scandi Standard Annual Report 2019. 1 Scandi Standard strives for mutual, responsible business relation- ships. Board member in Oriola-KD EVP Consumer Business HKScan Oyj Finland.